The crosstalk between gut microbiota and obesity and related metabolic disorders
- PMID: 27192213
- DOI: 10.2217/fmb-2015-0024
The crosstalk between gut microbiota and obesity and related metabolic disorders
Abstract
Obesity and related metabolic diseases are currently a threat to global public health. The occurrence and development of these conditions result from the combined effects of multiple factors. The human gut is a diverse and vibrant microecosystem, and its composition and function are a focus of research in the fields of life science and medicine. An increasing amount of evidence indicates that interactions between the gut microbiota and their genetic predispositions or dietary changes may be key factors that contribute to obesity and other metabolic diseases. Defining the mechanisms by which the gut microbiota influence obesity and related chronic metabolic diseases will bring about revolutionary changes that will enable practitioners to prevent and control metabolic diseases by targeting the gut microbiota.
Keywords: gut microbiota; intervention; metabolic disease.
Similar articles
-
Gut microbiota and obesity: Concepts relevant to clinical care.Eur J Intern Med. 2018 Feb;48:18-24. doi: 10.1016/j.ejim.2017.10.005. Epub 2017 Oct 27. Eur J Intern Med. 2018. PMID: 29110901 Review.
-
The role of the gut microbiota in metabolic health.FASEB J. 2015 Aug;29(8):3111-23. doi: 10.1096/fj.14-269514. Epub 2015 Apr 28. FASEB J. 2015. PMID: 25921831 Review.
-
[Gut microbiota and immune crosstalk in metabolic disease].Biol Aujourdhui. 2017;211(1):1-18. doi: 10.1051/jbio/2017008. Epub 2017 Jul 6. Biol Aujourdhui. 2017. PMID: 28682223 Review. French.
-
Western diets, gut dysbiosis, and metabolic diseases: Are they linked?Gut Microbes. 2017 Mar 4;8(2):130-142. doi: 10.1080/19490976.2016.1270811. Epub 2017 Jan 6. Gut Microbes. 2017. PMID: 28059614 Free PMC article. Review.
-
Emerging role of intestinal microbiota and microbial metabolites in metabolic control.Diabetologia. 2017 Apr;60(4):613-617. doi: 10.1007/s00125-016-4192-0. Epub 2016 Dec 24. Diabetologia. 2017. PMID: 28013341
Cited by
-
Gut Microbiota Modification via Glucagon-like Peptide-1 with Beneficial Neuroprotective Effects.Middle East J Dig Dis. 2022 Apr;14(2):235-243. doi: 10.34172/mejdd.2022.278. Epub 2022 Apr 30. Middle East J Dig Dis. 2022. PMID: 36619150 Free PMC article. Review.
-
Environmental risk factors of type 2 diabetes-an exposome approach.Diabetologia. 2022 Feb;65(2):263-274. doi: 10.1007/s00125-021-05618-w. Epub 2021 Nov 18. Diabetologia. 2022. PMID: 34792619 Review.
-
Comprehensive Approach to Medical Nutrition Therapy in Patients with Type 2 Diabetes Mellitus: From Diet to Bioactive Compounds.Antioxidants (Basel). 2023 Apr 10;12(4):904. doi: 10.3390/antiox12040904. Antioxidants (Basel). 2023. PMID: 37107279 Free PMC article. Review.
-
A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder.Cell Signal. 2021 Nov;87:110121. doi: 10.1016/j.cellsig.2021.110121. Epub 2021 Aug 23. Cell Signal. 2021. PMID: 34438017 Free PMC article.
-
Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes.Front Immunol. 2020 Dec 8;11:590685. doi: 10.3389/fimmu.2020.590685. eCollection 2020. Front Immunol. 2020. PMID: 33363537 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical